HaystackAnalytics

1 known investors

Haystack Analytics develops an NGS-based diagnostic test (UID) for rapid pathogen identification in sepsis and infectious disease cases, targeting clinicians and hospitals. The technology identifies over 1,200 pathogens within 12 hours to inform antibiotic treatment decisions.